HBx could also interact with non-muscle myosin heavy chain IIA (MYH9) and up-regulate it via modulating glycogen synthase kinase 3β (GSK3β)/β-catenin/c-Jun signaling pathway, contributing to promoted tumor stemness in HCC cells. Here, MYH9 is linked to hepatocellular carcinoma.